Ind-Swift Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Ind-Swift Lab.	Sakar Healthcare	Fredun Pharma
Operational Metrics
Pharmaceuticals
Total reactor capacity	700.0 kL	n/a	n/a
DMF Filingsby API	474.0 .	n/a	n/a
R&D as a % of Total Sales	2.9 %	n/a	n/a
Financials
5 yr Average ROE	14.7 %	8.14 %	12.85 %
5yr average Equity Multiplier	2.17	1.76	2.76
5yr Average Asset Turnover Ratio	0.66	0.45	1.02
5yr Avg Net Profit Margin	16.17 %	10.03 %	4.66 %
Price to Book	1.26	5.54	5.33
P/E	42.24	58.98	45.45
5yr Avg Cash Conversion Cycle	15.71 Days	18.72 Days	130.49 Days
Inventory Days	103.91 Days	51.79 Days	169.92 Days
Days Receivable	105.66 Days	53.06 Days	77.49 Days
Days Payable	107.02 Days	115.64 Days	112.96 Days
5yr Average Interest Coverage Ratio	21.19	4.85	2.33
5yr Avg ROCE	12.09 %	8.92 %	27.08 %
5yr Avg Operating Profit Margin	14.94 %	24.94 %	12.26 %
5 yr average Debt to Equity	0.91	0.49	0.95
5yr CAGR Net Profit	n/a	10.38 %	15.87 %
5yr Average Return on Assets	11.49 %	4.54 %	4.74 %
Shareholdings
Promoter Holding	42.99 %	52.86 %	44.17 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.99 %	-7.86 %	-5.98 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Ind-Swift Lab.	Sakar Healthcare	Fredun Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Loan Licensing 0 Export 0 CDMO 0 0	Product Wise Break-Up Loan Licensing 5.0 Export 73.0 Pharmaceutical 0 0 CDMO 22.0	Product Wise Break-Up Loan Licensing 0 Export 0 Pharmaceutical 0 Pharmaceutical 100.0 CDMO 0
Location Wise Break-Up	Location Wise Break-Up India 27.72 International 0 Domestic 0 Rest of the World 0 Others 72.28	Location Wise Break-Up India 0 Rest of the World 0 Domestic 44.52 International 55.48	Location Wise Break-Up India 83.13 Rest of the World 16.86 Domestic 0 International 0 Others 0.01
Operating Profit Break-Up	Operating Profit Break-Up India 18.87 Others 81.13	-	-
Asset Break-Up	Asset Break-Up India 67.55 Others 32.45	-	-